Search icon

vCardio Inc.

Company claim

Is this your business?

Get access!

Company Details

Name: vCardio Inc.
Legal type: Foreign Corporation
Status: Active
Standing: Good
Profit or Non-Profit: Profit
File Date: 27 May 2020 (5 years ago)
Organization Date: 10 Mar 2020 (5 years ago)
Authority Date: 27 May 2020 (5 years ago)
Last Annual Report: 25 Mar 2024 (a year ago)
Organization Number: 1098259
Industry: Engineering, Accounting, Research, Management & Related Services
Number of Employees: Small (0-19)
ZIP code: 40206
City: Louisville
Primary County: Jefferson County
Principal Office: 322 S Birchwood Ave, Louisville, KY 40206
Place of Formation: DELAWARE

Registered Agent

Name Role
Jeff Cummins Registered Agent

Authorized Rep

Name Role
Jeff Cummins Authorized Rep

Officer

Name Role
Jeff Cummins Officer

President

Name Role
Jeff Cummins President

Director

Name Role
Jeff Cummins Director
Eric Berson Director
Shahab Ghafghazi Director
Josh Nickols Director

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
FFKEQLFJ7JG3
CAGE Code:
8NXA3
UEI Expiration Date:
2024-11-19

Business Information

Division Name:
VCARDIO
Activation Date:
2023-11-22
Initial Registration Date:
2020-07-26

Filings

Name File Date
Annual Report 2024-03-25
Annual Report 2023-03-26
Annual Report 2022-03-08
Annual Report 2021-04-17

USAspending Awards / Financial Assistance

Date:
2022-02-10
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
METHOD FOR RAPID NON-INVASIVE ASSESSMENT OF CORONARY STENOSIS - VCARDIO, INC METHOD FOR RAPID NON-INVASIVE ASSESSMENT OF CORONARY STENOSIS PROJECT SUMMARY WE HAVE DEVELOPED A NON-INVASIVE TECHNIQUE FOR QUANTIFYING THE SEVERITY OF STENOSIS (BLOCKAGE) IN CORONARY ARTERIES. ONE MILLION INVASIVE CORONARY ANGIOGRAPHY (ICA) PROCEDURES ARE PERFORMED EVERY YEAR IN PATIENTS WHO PRESENT WITH CHEST PAIN OR ARE KNOWN TO HAVE STABLE CORONARY ARTERY DISEASE (CAD). THE GOAL OF THE PROCEDURE IS TO DETERMINE IF THERE IS ANY SIGNIFICANT STENOSIS THAT LIMITS BLOOD FLOW TO THE HEART MUSCLE IN THE CORONARY ARTERIES. ALMOST HALF OF ICAS CULMINATE IN STENT PLACEMENT IN CORONARY ARTERIES IN ORDER TO RELIEVE THE BLOCKAGE OF BLOOD FLOW. THE CARDIOLOGIST PERFORMING THE PROCEDURE IN THE CATHETERIZATION LAB DETERMINES THE SIGNIFICANCE OF THE STENOSIS BY ONE OF TWO METHODS: EITHER BY VISUALLY ESTIMATING THE DEGREE OF STENOSIS (‘EYEBALLING’ THE STENOSIS), WHICH IS THE ROUTINE PRACTICE AND IS DONE IN THE MAJORITY OF PATIENTS, OR BY INVASIVELY MEASURING FRACTIONAL FLOW RESERVE (PRESSURE-WIRE FFR), WHICH IS THE GOLD STANDARD TEST. HOWEVER, PRESSURE- WIRE FFR IS ONLY PERFORMED IN 10-20% OF PATIENTS BECAUSE IT IS INVASIVE, EXPENSIVE, AND TIME- CONSUMING, AND REQUIRES MORE RADIATION AND CONTRAST EXPOSURE. THE PROPOSED TECHNOLOGY PROVIDES AN ACCURATE, HIGHLY SENSITIVE AND SPECIFIC, NON-INVASIVE METHOD TO ASSESS THE SIGNIFICANCE OF CORONARY STENOSIS THROUGH CORONARY ANGIOGRAPHY WITHOUT PRESSURE-WIRE FFR MEASUREMENT. WHEN PERFORMED IN REAL-TIME, UNDER 2 MINUTES, THIS ALLOWS THE CARDIOLOGIST TO MAKE AN INFORMED DECISION REGARDING STENT PLACEMENT. SUCH A METHOD WOULD DELIVER THE BENEFITS OF PRESSURE-WIRE FFR MEASUREMENT IN TERMS OF COST SAVINGS AND IMPROVEMENT IN PATIENT SYMPTOMS, WHILE AVOIDING DISADVANTAGES SUCH AS EXTRA COST FOR THE PROCEDURE AND TIME BURDEN. IT PERFORMS FAVORABLY COMPARED TO COMPETING TECHNOLOGY IN TERMS OF ACCURACY BUT IS SUPERIOR TO COMPETITION WITH REGARDS TO THE TIME REQUIRED TO RUN THE SOFTWARE. THIS ALLOWS US TO PROVIDE A TRULY REAL-TIME SOLUTION FOR QUANTIFICATION OF CORONARY STENOSIS. OUR APPROACH USES REDUCED ORDER MODELING METHODS TO MODEL CORONARY BLOOD FLOW ACROSS STENOTIC CORONARY LESIONS AND ASSESS THE DEGREE OF STENOSIS SEVERITY BY INCORPORATING RESIDENCE TIME OF BLOOD FLOW THROUGH THE STENOTIC SEGMENTS. THE MAJOR ADVANTAGE OF THIS APPROACH OVER THE COMPETING SOLUTIONS IS ITS POTENTIAL TO DELIVER A REAL-TIME VIRTUAL SOLUTION WITHIN SECONDS. ONCE IMPLEMENTED, THE SOLUTION WOULD MERGE SEAMLESSLY WITH THE CURRENT CATHETERIZATION LAB EQUIPMENT AND PROVIDE A REAL-TIME, OBJECTIVE TOOL FOR ASSESSMENT OF CORONARY LESIONS BY THE TREATING CARDIOLOGISTS. THE OBJECTIVE IS TO SCALE THE STUDY FROM AN INITIAL SUCCESSFUL 54 PATIENT STUDY UP TO 500 PATIENTS (400 PATIENTS IN DERIVATION COHORT AND 100 PATIENTS IN VALIDATION COHORT) BY CONDUCTING A RETROSPECTIVE STUDY IN PATIENTS WITH KNOWN CAD WHO HAVE UNDERGONE CORONARY ANGIOGRAPHY AND PRESSURE-WIRE FFR MEASUREMENT FOR CLINICAL INDICATIONS.
Obligated Amount:
229693.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Reviews Leave a review

This company hasn't received any reviews.

Financial Incentive

Program Program Status Average Hourly Wage Project Cost Incentive Amount Initial Jobs New Jobs Date of Action Approval Type
SBIR/STTR Active - $90,777 $90,777 - - 2023-01-01 Final

Sources: Kentucky Secretary of State